Net Income változás Dátum
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
ALKERMES USD 47.76M 189.31M 2023-09
Alnylam Pharmaceuticals USD -137870000 285.62M 2023-12
Biogen USD 249.7M 317.8M 2023-12
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Cara Therapeutics USD -28032000 3.45M 2023-09
Corcept Therapeutics USD 31.35M 23K 2023-12
Cytokinetics USD -136896000 7.47M 2023-12
Eisai JPY 2.79B 17.55B 2023-09
Eli Lilly USD 2.19B 2.25B 2023-12
Incyte USD 201.08M 29.81M 2023-12
Intra Cellular Therapies USD -28579000 4.32M 2023-12
J&J USD 4.05B 21.98B 2023-12
Marinus Pharmaceuticals USD -32972000 1.04M 2023-09
Moderna USD 217M 3.85B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Pfizer USD -3368000000 986M 2023-12
PTC Therapeutics USD -155792000 22.82M 2023-12
Sarepta Therapeutics USD -40937000 17M 2023-09
Ultragenyx Pharmaceutical USD -123190000 36.46M 2023-12
Vanda Pharmaceuticals USD 1.52M 1.73M 2023-06
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



Acadia Pharmaceuticals Nettó Jövedelem - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.